Acquisition adds complementary dermatology product to the Pelthos portfolio anchored by ZELSUVMIXepi is a novel FDA-approved topical treatment for impetigo that addresses a critical unmet need in anti ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback